Background Although mammography screening is recommended in most European
countries, the balance between the benefits and harms of different screening intervals is still …

Background The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast
cancer control through short-term declines in screening and delays in diagnosis and …

Background: Mammography screening can lead to overdiagnosis—that is, screen-detected
breast cancer that would not have caused symptoms or signs in the remaining lifetime …

Importance Given recent advances in screening mammography and adjuvant therapy
(treatment), quantifying their separate and combined effects on US breast cancer mortality …

Objective Assumptions on the natural history of ductal carcinoma in situ (DCIS) are
necessary to accurately model it and estimate overdiagnosis. To improve current estimates …

Background: Screening mammography guidelines do not explicitly consider racial
differences in breast cancer epidemiology, treatment, and survival. Objective: To compare …

Importance The effects of breast cancer incidence changes and advances in screening and
treatment on outcomes of different screening strategies are not well known. Objective To …

Background Digital breast tomosynthesis (DBT) is increasingly being used for routine breast
cancer screening. We projected the long-term impact and cost-effectiveness of DBT …

Background: Surveillance with annual mammography and breast magnetic resonance
imaging (MRI) is recommended for female survivors of childhood cancer treated with chest …

Abstract Background Populations of African American or Black women have persistently
higher breast cancer mortality than the overall US population, despite having slightly lower …